News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab
Jul 1, 2024, 06:09

FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma – Genmab

Genmab shared a post on LinkedIn:

“Breaking News:

The FDA has approved our medicine for the treatment of adults with relapsed/refractory follicular lymphoma who have received at least two prior therapies.

This approval marks the second FDA-approved indication for our therapy, developed in collaboration with AbbVie.”

treatment

Source: Genmab/LinkedIn

AbbVie cancer cancer treatment FDA Genmab OncoDaily Oncology refractory follicular lymphoma
Blog
Aug 27, 2024, 23:36
Natenael Eshetu: Ethiopian Society of Hematology and Oncology has been accredited as a CPD provider
Blog
Aug 27, 2024, 23:34
Debra Patt: McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists and Research Institute’s Core Ventures
Blog
Aug 27, 2024, 23:32
Yeva Margaryan: Honored to be a speaker at the Economist Impact’s 10th World Cancer Series Europe event
Insight
Aug 27, 2024, 23:25
Maria Natalia Gandur Quiroga: Key Findings from a Study on Intermediate-Risk Prostate Cancer
Insight
Aug 27, 2024, 23:23
Thanh Tam Nguyen: Our group-based behavioural activation manual and training material have been successfully used for lung cancer patients
Blog
Aug 27, 2024, 23:21
Lung Cancer Policy Network is hosting an informal networking event on how lung cancer policy can be improved worldwide
Insight
Aug 27, 2024, 23:20
In Germany, patients often lack the ability to navigate the complex healthcare system - ABC Global Alliance
Insight
Aug 27, 2024, 23:18
Explore the current therapeutic landscape for Lung Cancer with Biagio Ricciuti at the upcoming ILCS24
Insight
Aug 27, 2024, 23:17
‘CUHK Entrepreneur Day’ 10th Anniversary Exhibition
Blog
Aug 27, 2024, 23:15
How risky is a second allogeneic stem cell transplantation? by Prof. Olaf Penack - IACH
Societies
Aug 27, 2024, 23:12
SIOPE BTG European Combined Neuro-Oncology Course - AIEOP
Societies
Aug 27, 2024, 23:11
The breakthroughs of medical innovation within 38 European countries - SIOP Europe